Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa

Author： Schwartz Richard H.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.22, Iss.9, 2006-09, pp. : 1725-1736

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of efficacy and safety of ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of acute diffuse otitis externa*

By Drehobl Margaret   Guerrero Juan Lorente   Lacarte Pilar Rivas   Goldstein Gary   Mata Francisco Sabater   Luber Stephen  

Current Medical Research and Opinion, Vol. 24, Iss. 12, 2008-12 ,pp. : 3531-3542

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa

By Roland Peter S.   Pien Francis D.   Schultz Craig C.   Henry Dan C.   Conroy Peter J.   Wall G. Michael   Garadi Rekha   Dupre Sheryl J.   Potts Susan L.   Hogg L. Gail   Stroman David W.    

Current Medical Research and Opinion, Vol. 20, Iss. 8, 2004-08 ,pp. : 1175-1183

Informa Healthcare

Access to resources Recommend Favorite

The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection

By Yamamoto Yoshihiro  

Journal of Infection and Chemotherapy, Vol. 18, Iss. 2, 2012-04 ,pp. : 241-246

Springer Publishing Company

Access to resources Recommend Favorite

Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: A randomized controlled trial

By Techapornroong Malee   Suankratay Chusana  

Scandinavian Journal of Infectious Diseases, Vol. 39, Iss. 10, 2007-12 ,pp. : 896-901

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16‐week, randomized, placebo‐controlled trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 699-702

John Wiley & Sons Inc

Access to resources Recommend Favorite